# Effect of Nesiritide Infusion on Insulin Sensitivity in Healthy Obese Insulin Resistant Subjects

> **NCT03234751** · PHASE1 · COMPLETED · sponsor: **AdventHealth Translational Research Institute** · enrollment: 6 (actual)

## Conditions studied

- Diabetes

## Interventions

- **DRUG:** Continous IV infusion of Nesiritide
- **DRUG:** Hyperinsulinemic euglycemic clamp
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03234751
- **Lead sponsor:** AdventHealth Translational Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-13
- **Primary completion:** 2018-09-24
- **Final completion:** 2020-02-19
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2020-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03234751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03234751, "Effect of Nesiritide Infusion on Insulin Sensitivity in Healthy Obese Insulin Resistant Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03234751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*